All Posts by
Dr. Boye, Dr. Calabro, Dr. Crosson, Siddhant (‘Sid’) Gupte and Russell Mellen all had the pleasure of presenting their newest data at the first virtual ASGCT meeting. Dr. Boye gave an update on the novel AAV capsids she has developed for intravitreal injection. Dr. Calabro gave a talk…
COVID-19 has changed everything. I’ve become a 6th and 4th grade teacher on top of being a PI. My students, postdocs, and staff have carefully navigated social distancing rules to do a much reduced number of experiments, but have made up for time lost in lab by writing grants and…
Today, Feb. 28th, the BLM helped celebrate Rare Disease Day. Russell Mellen presented his work to develop an AAV-CRISPR/Cas9- based approach for a pediatric retinal disease, cone-rod dystrophy. Dr. Kaitlyn Calabro presented her work to develop a dual AAV vector-mediated therapy for MYO7A Usher syndrome. We also took time out…
On February 25th, Dr. Calabro showed what being a good scientist is all about. She served as a guest lecturer at P.K. Yonge elementary school where she taught the kiddos (including Brett Looney’s son!) what it meant to be a scientist. Here she is showing them how cool you can…
It wouldn’t be a BLM Christmas party without an epic White Elephant gift exchange. This year’s winners- my new Danny Devito pillow and Russell’s fashionable shirt. Love you crazy kids!…
Kaitlyn Calabro successfully defended her Ph.D. thesis on October 24th, 2019. Every student stands out for a particular reason. For Kait, it was her height (or lack thereof!), and her incredible work ethic. I knew from the first week of her lab rotation that she had enough elbow grease to…
After an exceptional 5 years as a postdoc in the Boye Lab, Shreyasi decided to get a ‘real job’ at Spark Therapeutics. We are lost without her super sweet voice announcing lab meeting every Friday! We’ll miss you Shreyasi and wish you all the best in your new endeavor!…
Shannon E. Boye, PhD ’06, has an eye for tackling some of the toughest sight-robbing vision problems.
Shannon Boye, PhD, University of Florida, talks about the advancement of her of gene therapy for Leber congenital amaurosis toward a clinical trial.
An experimental treatment sacrifices rod cell function to save cone cells in mice, preventing retinal degeneration, researchers report. …
